These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 16338275)

  • 1. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.
    Kringen MK; Chalabianloo F; Bernard JP; Bramness JG; Molden E; Høiseth G
    Ther Drug Monit; 2017 Oct; 39(5):550-555. PubMed ID: 28723731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
    Dobrinas M; Crettol S; Oneda B; Lahyani R; Rotger M; Choong E; Lubomirov R; Csajka C; Eap CB
    Pharmacogenet Genomics; 2013 Feb; 23(2):84-93. PubMed ID: 23249875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomeric metabolic interactions and stereoselective human methadone metabolism.
    Totah RA; Allen KE; Sheffels P; Whittington D; Kharasch ED
    J Pharmacol Exp Ther; 2007 Apr; 321(1):389-99. PubMed ID: 17259447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.
    Dennis BB; Bawor M; Thabane L; Sohani Z; Samaan Z
    PLoS One; 2014; 9(1):e86114. PubMed ID: 24489693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.
    Wang SC; Ho IK; Tsou HH; Tian JN; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Chen CY; Liu SC; Wu HY; Chan HW; Tsai MH; Lin PS; Liu YL
    J Clin Psychopharmacol; 2011 Aug; 31(4):463-9. PubMed ID: 21694616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.
    Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H
    Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y; Fang WB; Lin SN; Moody DE
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
    Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
    Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.
    Eap CB; Crettol S; Rougier JS; Schläpfer J; Sintra Grilo L; Déglon JJ; Besson J; Croquette-Krokar M; Carrupt PA; Abriel H
    Clin Pharmacol Ther; 2007 May; 81(5):719-28. PubMed ID: 17329992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans.
    Kobayashi K; Morita J; Chiba K; Wanibuchi A; Kimura M; Irie S; Urae A; Ishizaki T
    Pharmacogenetics; 2004 Aug; 14(8):549-56. PubMed ID: 15284537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
    Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK
    Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.
    Ekhart C; Doodeman VD; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Jun; 18(6):515-23. PubMed ID: 18496131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.
    Bogen DL; Perel JM; Helsel JC; Hanusa BH; Romkes M; Nukui T; Friedman CR; Wisner KL
    Psychopharmacology (Berl); 2013 Jan; 225(2):441-51. PubMed ID: 22926004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients.
    Wang SC; Ho IK; Wu SL; Liu SC; Kuo HW; Lin KM; Liu YL
    Biomed Chromatogr; 2010 Jul; 24(7):782-8. PubMed ID: 19904716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.
    Scordo MG; Spina E; Dahl ML; Gatti G; Perucca E
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):296-301. PubMed ID: 16236141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CYP2B6 in stereoselective human methadone metabolism.
    Totah RA; Sheffels P; Roberts T; Whittington D; Thummel K; Kharasch ED
    Anesthesiology; 2008 Mar; 108(3):363-74. PubMed ID: 18292673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.